Cutler Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-100
Closed -$1K 2359
2023
Q4
$1K Buy
+100
New +$6.1K ﹤0.01% 3275
2023
Q1
Sell
-170
Closed -$3K 3825
2022
Q4
$3K Sell
170
-600
-78% -$84.5K ﹤0.01% 3428
2022
Q3
$11K Buy
770
+170
+28% +$19.2K ﹤0.01% 3047
2022
Q2
$22K Buy
600
+450
+300% +$34.9K ﹤0.01% 2584
2022
Q1
$7K Buy
150
+125
+500% +$16.5K ﹤0.01% 3853
2021
Q4
$2K Sell
25
-114
-82% -$26.9K ﹤0.01% 4669
2021
Q3
$3K Buy
+139
New +$39.7K ﹤0.01% 4763
2020
Q3
Sell
-232
Closed -$36K 4679
2020
Q2
$36K Hold
232
﹤0.01% 1970
2020
Q1
$77K Buy
+232
New +$226K ﹤0.01% 1485
2019
Q4
Sell
-162
Closed -$175K 3985
2019
Q3
$175K Sell
162
-579
-78% -$884K 0.02% 763
2019
Q2
$144K Buy
741
+579
+357% +$1M 0.01% 892
2019
Q1
$82K Sell
162
-463
-74% -$815K 0.01% 1113
2018
Q4
$202K Hold
625
0.02% 639
2018
Q3
$118K Sell
625
-301
-33% -$622K 0.01% 1103
2018
Q2
$259K Sell
926
-464
-33% -$1.06M 0.02% 674
2018
Q1
$338K Sell
1,390
-525
-27% -$1.34M 0.03% 562
2017
Q4
$167K Sell
1,915
-864
-31% -$1.75M 0.01% 1076
2017
Q3
$158K Buy
2,779
+100
+4% +$140K 0.01% 1324
2017
Q2
$142K Buy
2,679
+1,583
+144% +$1.91M 0.01% 1561
2017
Q1
$45K Sell
1,096
-2,880
-72% -$2.94M ﹤0.01% 2517
2016
Q4
$180K Buy
3,976
+1,066
+37% +$846K 0.01% 1371
2016
Q3
$206K Buy
2,910
+555
+24% +$402K 0.01% 1177
2016
Q2
$431K Sell
2,355
-2,099
-47% -$1.19M 0.02% 662
2016
Q1
$1.23M Sell
4,454
-2,957
-40% -$1.82M 0.08% 215
2015
Q4
$2.5M Buy
+7,411
New +$7.4M 0.14% 125

Other funds holding BLUE

Cutler Group's BLUE Position: Q1 2024 in Review

Cutler Group held its bluebird bio (BLUE) position steady in Q1 2024 at 40 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

Cutler Group first reported a position in BLUE in Q4 2015 and has held it in 22 quarters since. The position peaked at $3.52M in Q4 2015. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Cutler Group held 40 shares of bluebird bio worth $1K as of Q1 2024.
  • Cutler Group left its bluebird bio share count unchanged in Q1 2024.
  • bluebird bio made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1952 holding.
  • Cutler Group first reported a position in bluebird bio in Q4 2015 and has held it in 22 quarters since.
  • Cutler Group's bluebird bio position peaked at $3.52M in Q4 2015.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.